Connection

Yeming Wang to Influenza, Human

Back to Details
This is a "connection" page, showing publications Yeming Wang has written about Influenza, Human.
Yeming Wang
Connection Strength
0.246
Influenza, Human
  1. Phase 2a, open-label, dose-escalating, multi-center pharmacokinetic study of favipiravir (T-705) in combination with oseltamivir in patients with severe influenza. EBioMedicine. 2020 Dec; 62:103125.
    View in: PubMed
    Score: 0.150
  2. Comparison of the Cepheid Xpert Xpress Flu/RSV assay and commercial real-time PCR for the detection of influenza A and influenza B in a prospective cohort from China. Int J Infect Dis. 2019 Mar; 80:92-97.
    View in: PubMed
    Score: 0.033
  3. Dynamic Variation and Reversion in the Signature Amino Acids of H7N9 Virus During Human Infection. J Infect Dis. 2018 07 13; 218(4):586-594.
    View in: PubMed
    Score: 0.032
  4. Application of extracorporeal membrane oxygenation in patients with severe acute respiratory distress syndrome induced by avian influenza A (H7N9) viral pneumonia: national data from the Chinese multicentre collaboration. BMC Infect Dis. 2018 01 08; 18(1):23.
    View in: PubMed
    Score: 0.031
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.